Jay Koyner to Multicenter Studies as Topic
This is a "connection" page, showing publications Jay Koyner has written about Multicenter Studies as Topic.
Connection Strength
0.055
-
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial). BMJ Open. 2023 04 06; 13(4):e068363.
Score: 0.055